Avacta Group (LON:AVCT) Shares Cross Below 200 Day Moving Average – Here’s Why

Shares of Avacta Group Plc (LON:AVCT) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 71.70 and traded as low as GBX 63. Avacta Group shares last traded at GBX 63.30, with a volume of 1,406,172 shares changing hands.

Avacta Group Price Performance

The company has a debt-to-equity ratio of 526.98, a quick ratio of 4.96 and a current ratio of 0.95. The company’s fifty day moving average price is GBX 69.48 and its 200 day moving average price is GBX 71.70. The firm has a market capitalization of £289.26 million, a price-to-earnings ratio of -6.85 and a beta of 1.12.

Avacta Group (LON:AVCT) last released its quarterly earnings data on Wednesday, September 30th. The biotechnology company reported GBX (4.23) earnings per share for the quarter. Avacta Group had a negative return on equity of 1,293.07% and a negative net margin of 35,730.97%. Equities research analysts expect that Avacta Group Plc will post -9.90 earnings per share for the current year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).